Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 1/20 | 0.49 |
| ▸ | BACE1 | P56817 | 1/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CNR1 | P21554 | 3/20 | 0.41 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 4/20 | 0.38 |
| ▸ | ESR1 | P03372 | 4/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.35 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8462541 | 0.88 | ESR1 (0.51) | NUDT1BACE1HSP90AA1CYP1A2CYP2D6 | |
| SCHEMBL68186 | 0.84 | NUDT1 (0.50) | NUDT1BACE1HSP90AA1CYP1A2CYP2D6 | |
| SCHEMBL3133679 | 0.84 | CYP2D6 (0.54) | NUDT1BACE1HSP90AA1CYP1A2CYP2D6 | |
| SCHEMBL29368513 | 0.84 | NUDT1 (0.50) | NUDT1BACE1HSP90AA1CYP1A2CYP2D6 | |
| SCHEMBL10596142 | 0.84 | CNR1 (0.56) | NUDT1BACE1HSP90AA1CYP1A2CNR1 | |
| Methane SCHEMBL27697714 | 0.83 | CYP2D6 (0.52) | NUDT1BACE1HSP90AA1CYP1A2CYP2D6 | |
| SCHEMBL13609954 | 0.83 | NUDT1 (0.49) | NUDT1BACE1HSP90AA1CYP1A2CYP2D6 | |
| SCHEMBL29623103 | 0.83 | NUDT1 (0.49) | NUDT1BACE1HSP90AA1CYP1A2CYP2D6 | |
| SCHEMBL11308536 | 0.82 | ALDH1A1 (0.52) | NUDT1BACE1HSP90AA1CYP1A2CYP2D6 | |
| SCHEMBL2913464 | 0.82 | NUDT1 (0.44) | NUDT1BACE1HSP90AA1CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7618713-B2 | interposed between circuit electrodes facing each other and electrically connects the electrodes in the pressing direction by pressing the facing electrodes against each other; the circuit-connecting material comprising as essential components, a curing agent and a hydroxy resin with radical polymer | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2009-11-17 | — | — | US | disclosed |
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| EP-1375463-A1 | OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Kansai Research Institute, Inc. (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | KRI, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
| EP-0329991-A1 | Aromatic polycarbonate film | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1989-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | ARCN1, RAD51, PAM | NUDT1 1116/4885BACE1 1553/4885HSP90AA1 556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.